Variant report
Variant | esv3340901 |
---|---|
Chromosome Location | chr6:144529309-144531807 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:144521656..144524186-chr6:144530530..144532324,2 | K562 | blood: | |
2 | chr6:144515219..144517320-chr6:144531063..144533998,2 | K562 | blood: | |
3 | chr6:144531404..144534251-chr6:144536008..144537588,2 | K562 | blood: | |
4 | chr6:144529710..144531964-chr6:144532893..144535500,2 | K562 | blood: | |
5 | chr6:144528833..144531316-chr6:144534219..144536823,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000217027 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558709215 | chr6:144529330-144529331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs145982415 | chr6:144529348-144529349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs111854123 | chr6:144529349-144529350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187428530 | chr6:144529385-144529386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574638185 | chr6:144529404-144529405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191466986 | chr6:144529450-144529451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs6903349 | chr6:144529453-144529454 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs182935000 | chr6:144529462-144529463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528503293 | chr6:144529463-144529464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545759167 | chr6:144529508-144529509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563707677 | chr6:144529538-144529539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572517190 | chr6:144529581-144529582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs539896678 | chr6:144529665-144529666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116351254 | chr6:144529706-144529707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs75964568 | chr6:144529712-144529713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564268663 | chr6:144529767-144529768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs533251086 | chr6:144529780-144529781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12211395 | chr6:144529804-144529805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs370537149 | chr6:144529805-144529806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186944947 | chr6:144529809-144529810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190210476 | chr6:144529812-144529813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570818746 | chr6:144529826-144529827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2146171 | chr6:144529863-144529864 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs547111863 | chr6:144529865-144529866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2146170 | chr6:144529877-144529878 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs2146169 | chr6:144529881-144529882 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs116209996 | chr6:144529888-144529889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148634962 | chr6:144529924-144529925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs367913913 | chr6:144529949-144529950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539316075 | chr6:144529953-144529954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557636799 | chr6:144530029-144530030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs569516592 | chr6:144530052-144530053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs58847604 | chr6:144530090-144530091 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs368589505 | chr6:144530100-144530101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs535246490 | chr6:144530110-144530111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs539884747 | chr6:144530167-144530168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558378153 | chr6:144530178-144530179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs182187890 | chr6:144530201-144530202 | Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
39 | rs141963907 | chr6:144530236-144530237 | Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73585264 | chr6:144530296-144530297 | Bivalent Enhancer ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs563696540 | chr6:144530314-144530315 | Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
42 | rs531143607 | chr6:144530350-144530351 | Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
43 | rs532232907 | chr6:144530365-144530366 | Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200200617 | chr6:144530372-144530373 | Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552458827 | chr6:144530389-144530390 | Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
46 | rs552856568 | chr6:144530457-144530458 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs78382101 | chr6:144530468-144530469 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs4446579 | chr6:144530480-144530481 | Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs547048916 | chr6:144530488-144530489 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs554300108 | chr6:144530527-144530528 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Endocrine pancreatic tumor | 17914106 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17142309 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:144522200-144530200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr6:144530200-144530400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr6:144530200-144530600 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr6:144530400-144536200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr6:144530800-144531000 | Enhancers | Fetal Brain Female | brain |
6 | chr6:144531200-144534400 | Weak transcription | Fetal Brain Female | brain |